MedTrace Logo

Effects Of Jandas Approach Vs PNF Technique On Pain, ROM, Disability, Endurance And QOL In Patients With LCS

NCT06737900 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2024-12-17

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to learn if the given interventions that is jandas approach versus Proprioceptive Neuromuscular Facilitation technique can treat pain, disability, range of motion, endurance and quality of life in patients with Lower cross syndrome on both genders and age group of 25-40 years. The main questions it aims to answer are:

Does jandas approach versus Proprioceptive neuromuscular facilitation technique improves pain, disability, range of motion, endurance and quality of life in patients with lower cross syndrome?

There is a comparison between two groups: Researchers will compare the jandas approach and proprioceptive neuromuscular facilitation technique to see if there is effects on pain, disability, range of motion, endurance and quality of life in patients with lower cross syndrome.

Participants in group A will be given

* Heating pad for 10 minutes
* Core stability exercises for 20 minutes with 10 seconds of rest intervals
* Proprioceptive Neuromuscular Facilitation technique was used for stretching of erector spinae, quadratus lumborum, rectus femoris and iliopsoas and rhythmic stabilization technique for strengthening. Stretching was performed using contract-relax technique in supine, prone and side lying positions. The Contract-Relax method included the target muscle to be lengthened and held in lengthened position while the patient contracted the Target-Muscle to its maximum position isometrically 3 to 6 seconds.
* Rhythmic stabilization technique was used to strengthen and stabilize the postural trunk muscles of hip: Abdominals and gluteal muscles strengthening and Participants in group B will be given
* Heating pad for 10 minutes
* Core stability exercises for another 20 minutes.
* After which it was treated with the Janda's approach of musculoskeletal pain that includes strengthening of the weakened muscles and stretching of the tightened muscles including Stretching exercise for erector spinae and back extensors muscles Stretching exercises for iliopsoas muscle and rectus femoris muscle Strengthening exercise for abdominal muscle and gluteal maximus muscle

Conditions

  • Lower Cross Syndrome

Interventions

OTHER

traditional physical therapy

* Heating pad for 10 minutes * Core stability exercises for 20 minutes with 10 seconds of rest intervals * Patients were advised to stretch for 5 minutes then perform lumber stability exercises. * These stability exercises included side bridges, supine extension bridge, straight leg raise in prone lying, alternate arm and leg raise from quadruped position and prone bridges. Both groups took sessions thrice a week for a total of 4 weeks.

OTHER

jandas approach

* Stretching exercise for erector spinae and back extensors muscles * Stretching exercises for iliopsoas muscle and rectus femoris muscle * Strengthening exercise for abdominal muscle and gluteal maximus muscle Stretching exercise was performed actively for 3 repetitions x 1 set and 4 days a week Strengthening exercise was performed for 10 second hold and 10 repetitions. All Exercises was performed 3 times per week for total of 4 weeks

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Amna Shahid, t-DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2024-12-31
Completion
2025-01-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06737900 on ClinicalTrials.gov